Based on data obtained by Streeck et al. studying HIV, these two proteins may interact to inhibit KLRG1+CD8+ T-cell effector function, leading to immune dysfunction in CLL patients [117]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.